ResearcherKawasaki Medical SchoolNo recent work listed
Keisuke Hino
Matched on ORCID iD 0000-0002-3297-1720; OpenAlex author ID A5025371497. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation. Last author DOI 10.1016/j.pan.2023.08.007↗
- Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis… Co-author DOI 10.1016/j.biopha.2022.113733↗
- Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12876-015-0340-0↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Koji Yoshida · 2 shared papers, 2015–2023 · strength 0.22
- Paper Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferat… DOI 10.1016/j.pan.2023.08.007↗
- Paper Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. DOI 10.1186/s12876-015-0340-0↗
- Reiji Nishimon · 1 shared paper, 2023 · strength 0.17
- Tomio Ueno · 1 shared paper, 2022 · strength 0.11
- 明 山内 · 1 shared paper, 2022 · strength 0.11
- Shuichiro Okamoto · 1 shared paper, 2022 · strength 0.11
- Masakiyo Sakaguchi · 1 shared paper, 2022 · strength 0.11
- Futoshi Kuribayashi · 1 shared paper, 2022 · strength 0.11
- Norihiko Sugisawa · 1 shared paper, 2022 · strength 0.11
- Robert M. Hoffman · 1 shared paper, 2022 · strength 0.11
- Masahiro Yamamura · 1 shared paper, 2022 · strength 0.11
- Tomoya Kawase · 1 shared paper, 2015 · strength 0.05
- Masafumi Nakamura · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.